Education
About Us
Working with TipRanks
Follow Us
Sanara MedTech (SMTI)
NASDAQ:SMTI
SMTI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$23.53 - $39.08
Previous CloseN/A
Volume5.72K
Average Volume (3M)44.92K
Market Cap
$299.56M
Enterprise Value$273.01M
Total Cash (Recent Filing)$16.96M
Total Debt (Recent Filing)$45.45M
Price to Earnings (P/E)―
Beta1.06
Next Earnings
Nov 17, 2025EPS Estimate
-0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding8,902,351
10 Day Avg. Volume51,320
30 Day Avg. Volume44,925
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue2.81
Enterprise Value/Gross Profit3.10
Enterprise Value/Ebitda194.79
Forecast
1Y Price Target
$49.50Price Target Upside45.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
EarningsSanara MedTech reported a net revenue of $25.8M in 2Q25, showing 28% year-over-year growth and surpassing projections.
Product DemandRevenue for soft tissue repair products increased by 28% year-over-year, driven by demand for CellerateRX Surgical Activated Collagen.
Bears Say
Debt ObligationsThe company has $44.2M of principal debt obligations, indicating a significant financial commitment.
Financial RisksRisks include lower-than-projected revenue growth of products and services, inability to secure additional customers, inability to launch new products or services, and potential dilution risk.
Sanara MedTech News
SMTI FAQ
What was Sanara MedTech’s price range in the past 12 months?
Sanara MedTech lowest stock price was $23.53 and its highest was $39.08 in the past 12 months.
What is Sanara MedTech’s market cap?
Sanara MedTech’s market cap is $299.56M.
When is Sanara MedTech’s upcoming earnings report date?
Sanara MedTech’s upcoming earnings report date is Nov 17, 2025 which is in 81 days.
How were Sanara MedTech’s earnings last quarter?
Sanara MedTech released its earnings results on Aug 13, 2025. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.44 by $0.21.
Is Sanara MedTech overvalued?
According to Wall Street analysts Sanara MedTech’s price is currently Undervalued.
Does Sanara MedTech pay dividends?
Sanara MedTech does not currently pay dividends.
What is Sanara MedTech’s EPS estimate?
Sanara MedTech’s EPS estimate is -0.22.
How many shares outstanding does Sanara MedTech have?
Sanara MedTech has 8,902,351 shares outstanding.
What happened to Sanara MedTech’s price movement after its last earnings report?
Sanara MedTech reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.44. Following the earnings report the stock price went up 16.199%.
Which hedge fund is a major shareholder of Sanara MedTech?
Currently, no hedge funds are holding shares in SMTI
Sanara MedTech Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$49.50 (45.85% Upside)
$49.50 (45.85% Upside)
Blogger Sentiment
Bullish
SMTI Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.38%
12-Months-Change
Fundamentals
Return on Equity
-25.78%
Trailing 12-Months
Asset Growth
34.59%
Trailing 12-Months
Company Description
Sanara MedTech
Sanara MedTech Inc. (SMTI) is a medical technology company focused on developing and commercializing advanced wound care products and regenerative medicine solutions. The company operates primarily in the healthcare sector, providing innovative treatment options that enhance healing processes for patients suffering from chronic wounds and other medical conditions. Sanara's core products include bioengineered wound care solutions and various medical devices that promote tissue regeneration and healing.
SMTI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Sanara MedTech reported strong revenue growth and profitability improvements in its Surgical segment, driven by product sales and operational efficiency. However, the THP segment continues to incur losses and requires strategic reevaluation, balancing the positive results from the Surgical segment.View all SMTI earnings summariesSMTI Stock 12 Month Forecast
Average Price Target
$49.50
▲(45.85% Upside)
Technical Analysis
Ownership Overview
41.62% Insiders
3.62% Mutual Funds
0.27% Other Institutional Investors
51.15% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---